DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Leonardi CL, Kimball AB, Papp KA. et al.
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Lancet 2008;
371: 1665-1674
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.